ETELCALCETIDE injection (Parsabiv)

Clinical Indication

Secondary hyperparathyroidism in adult patients with chronic kidney disease on haemodialysis therapy


Inline with NICE TA 448

Date of classification

March 2017


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.